Long-term functional outcomes in tumour stage T2 glottic carcinoma after radiotherapy

被引:3
作者
Hendriksma, M. [1 ]
Heijnen, B. J. [1 ]
Verbist, B. M. [2 ]
de Jong, M. A. [3 ]
Langeveld, A. P. M. [1 ]
van Benthem, P. P. G. [1 ]
Sjogren, E., V [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands
[3] Leiden Univ, Med Ctr, Dept Radiat Oncol, Leiden, Netherlands
关键词
Laryngeal Neoplasms; Radiotherapy; Quality Of Life; Voice; Deglutition; QUALITY-OF-LIFE; VOICE HANDICAP INDEX; NECK-CANCER; HEAD; QUESTIONNAIRE; VALIDATION; QLQ-C30; MODULE;
D O I
10.1017/S0022215122001682
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
ObjectiveTo evaluate the long-term functional outcomes in patients who received primary radiotherapy for tumour-node stage T2N0 glottic carcinoma, stratified for tumour extension. MethodsA cross-sectional study was performed on patients who were treated with radiotherapy for T2N0 glottic carcinoma. Four questionnaires were used to measure different aspects of functional outcome. In addition, objective evaluation and perceptual analysis were performed. ResultsFourteen patients were included in this study. The median time between the start of radiotherapy and assessment was 42 months (range, 26-143 months). Patients reported high-level functioning, with low symptom scores and good swallowing function, and showed a median dysphonia grade of 1.5. The median Voice Handicap Index-30 score was 17.5. ConclusionPatients with T2N0 glottic carcinoma treated with radiotherapy had good long-term quality of life, with low symptom scores, good swallowing functioning and slightly elevated voice outcome parameters.
引用
收藏
页码:685 / 690
页数:6
相关论文
共 24 条
[1]   THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].
AARONSON, NK ;
AHMEDZAI, S ;
BERGMAN, B ;
BULLINGER, M ;
CULL, A ;
DUEZ, NJ ;
FILIBERTI, A ;
FLECHTNER, H ;
FLEISHMAN, SB ;
DEHAES, JCJM ;
KAASA, S ;
KLEE, M ;
OSOBA, D ;
RAZAVI, D ;
ROFE, PB ;
SCHRAUB, S ;
SNEEUW, K ;
SULLIVAN, M ;
TAKEDA, F .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376
[2]   Factors affecting the quality of voice in the early glottic cancer treated with radiotherapy [J].
Agarwal, Jai Prakash ;
Baccher, Gurmit K. ;
Waghmare, Chaitali M. ;
Mallick, Indranil ;
Ghosh-Laskar, Sarbani ;
Budrukkar, Ashwini ;
Pai, Prathamesh ;
Chaturvedi, Pankaj ;
D'Cruz, Anil ;
Shrivastava, Shyam K. ;
Dinshaw, Ketayun A. .
RADIOTHERAPY AND ONCOLOGY, 2009, 90 (02) :177-182
[3]   Radiotherapy for T1-2N0 glottic cancer: a multivariate analysis of predictive factors for the long-term outcome in 1050 patients and a prospective assessment of quality of life and voice handicap index in a subset of 233 patients [J].
Al-Mamgani, A. ;
van Rooij, P. H. ;
Woutersen, D. P. ;
Mehilal, R. ;
Tans, L. ;
Monserez, D. ;
de Jong, Baatenburg R. J. .
CLINICAL OTOLARYNGOLOGY, 2013, 38 (04) :306-312
[4]   Quality of life and voice assessment in patients with early-stage glottic cancer [J].
Arias, Fernando ;
Ignacio Arraras, Juan ;
Asin, Gemma ;
Itziar Uzcanga, Maria ;
Maravi, Enrique ;
Chicata, Volker ;
Eito, Clara ;
Zarandona, Uxue ;
Mora, Itxaso ;
Vila, Meritxell ;
Angel Dominguez, Miguel .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2015, 37 (03) :340-346
[5]   Voice outcomes after radiotherapy treatment for early glottic cancer: Assessment using multidimensional tools [J].
Bibby, Jessica R. L. ;
Cotton, Susan M. ;
Perry, Alison ;
Corry, June F. .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2008, 30 (05) :600-610
[6]   DEVELOPMENT OF A EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER (EORTC) QUESTIONNAIRE MODULE TO BE USED IN QUALITY-OF-LIFE ASSESSMENTS IN HEAD AND NECK-CANCER PATIENTS [J].
BJORDAL, K ;
AHLNERELMQVIST, M ;
TOLLESSON, E ;
JENSEN, AB ;
RAZAVI, D ;
MAHER, EJ ;
KAASA, S .
ACTA ONCOLOGICA, 1994, 33 (08) :879-885
[7]   A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients [J].
Bjordal, K ;
de Graeff, A ;
Fayers, PM ;
Hammerlid, E ;
van Pottelsberghe, C ;
Curran, D ;
Ahlner-Elmqvist, M ;
Maher, EJ ;
Meyza, JW ;
Brédart, A ;
Söderholm, AL ;
Arraras, JJ ;
Feine, JS ;
Abendstein, H ;
Morton, RP ;
Pignon, T ;
Huguenin, P ;
Bottomly, A ;
Kaasa, S .
EUROPEAN JOURNAL OF CANCER, 2000, 36 (14) :1796-1807
[8]  
Boersma P., 2004, STEM SPR TAALPATHOLO, V12, P237
[9]  
Brierley JD., 2016, TNM Classification of Malignant Tumors, Eighth Edition
[10]  
Chen AY, 2001, ARCH OTOLARYNGOL, V127, P870